Real-time thyroid nodule care

  • Sally E. Carty
    Reprint requests: Sally E. Carty, MD, Professor of Surgery, Department of Surgery, Division of Endocrine Surgery, University of Pittsburgh, Kaufmann Building, Suite 101, 3471 Fifth Ave, Pittsburgh, PA, 15213. (S.E.Carty)
    Department of Surgery, Division of Endocrine Surgery, University of Pittsburgh, Pittsburgh, PA
    Search for articles by this author
Published:November 07, 2022DOI:
      Salutations! I chose the field of endocrine surgery because of its fascinating complexity, long-term patient care and multidisciplinary nature. Today, our high-volume program manages thyroid molecular results every day, and I am grateful to have helped evolve the field for patients, thyroidologists, and health care costs. In this brief commentary, I will give examples of real-time thyroid molecular use and highlight opportunities for future study.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Haugen B.R.
        • Alexander E.K.
        • Bible K.C.
        • et al.
        2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer.
        Thyroid. 2016; 26: 1-133
        • Patel K.N.
        • Yip L.
        • Lubitz C.C.
        • Grubbs E.G.
        • et al.
        The American Association of Endocrine Surgeons Guidelines for the definitive surgical management of thyroid disease in adults.
        Ann Surg. 2020; 271: e21-e293
        • Gharib H.
        • Goellner J.R.
        Fine-needle aspiration biopsy of the thyroid: an appraisal.
        Ann Int Med. 1993; 118: 282-289
        • Livhits M.J.
        • Zhu C.Y.
        • Kuo E.J.
        • et al.
        Effectiveness of molecular testing techniques for diagnosis of indeterminate thyroid nodules: a randomized clinical trial.
        JAMA Oncol. 2021; 7: 70-77
        • Nicholson K.J.
        • Roberts M.S.
        • McCoy K.L.
        • Carty S.E.
        • Yip L.
        Molecular testing versus diagnostic lobectomy in Bethesda III/IV thyroid nodules: a cost-effectiveness analysis.
        Thyroid. 2019; 29: 1237-1243
        • Guan H.
        • Toraldo G.
        • Cerda S.
        • et al.
        Utilities of RAS mutations in preoperative fine needle biopsies for decision making for thyroid nodule management: results from a single-center prospective cohort.
        Thyroid. 2020; 30: 536-547
        • Carty S.E.
        • Ohori N.P.
        • Hilko D.A.
        • et al.
        The clinical utility of molecular testing in the management of thyroid follicular neoplasms (Bethesda IV Nodules).
        Ann Surg. 2020; 272: 621-627
        • Yip L.
        • Nikiforova M.N.
        • Yoo J.Y.
        • et al.
        Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer.
        Ann Surg. 2015; 262: 519-525
        • Xing M.
        • Alzhrani A.S.
        • Carson K.A.
        • et al.
        Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
        JAMA. 2013; 309: 1493-1501
        • Yip L.
        • Gooding W.E.
        • Nikitski A.
        • et al.
        Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: a matched case-control study.
        Cancer. 2021; 127: 1179-1187
      1. Liu JB, Ramonell KM, Carty SE, et al. Association of comprehensive thyroid cancer molecular profiling with tumor phenotype and cancer-specific outcomes. Surgery. Accessed October 19, 2022.

        • Cancer Genome Atlas Research Network
        Integrated genomic characterization of papillary thyroid carcinoma.
        Cell. 2014; 159: 676-690
      2. Chiosea S, Hodak S, Yip L, et al. Molecular Profiling of 50,734 Bethesda II-VI Thyroid Nodules by ThyroSeq v3 Genomic Classifier: Implications for personalized management. Proceedings of 2021 American Thyroid Association Annual Meeting.

        • Ma L.X.
        • Espin-Garcia O.
        • Bedard P.L.
        • et al.
        Clinical application of next generation sequencing in advanced thyroid cancers.
        Thyroid. 2022; 32: 657-666
        • Figge J.J.
        • Gooding W.E.
        • Steward D.L.
        • et al.
        Do ultrasound patterns and clinical parameters inform the probability of thyroid cancer predicted by molecular testing in nodules with indeterminate cytology?.
        Thyroid. 2021; 31: 1673-1682